Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 82 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Eltrombopag in chronic myelomonocytic leukemia with severe thrombocytopenia. A Groupe Francophone des Myélodysplasies (GFM) study.
Rabian F, Chevret S, Gruson B, Thépot S, Walter-Petrich A, Braun T, Vey N, Torregrosa-Diaz JM, Peterlin P, Toma A, D'Aveni M, Delaunay J, Legros L, Droin N, Chermat F, Lusina D, Adès L, Sapena R, Solary E, [...] Itzykson R
Leukemia, 38(11):2510-2513, 12 Sep 2024
Cited by: 0 articles | PMID: 39266637
Add to export list
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia.
Deschamps P, Wacheux M, Gosseye A, Morabito M, Pagès A, Lyne AM, Alfaro A, Rameau P, Imanci A, Chelbi R, Marchand V, Renneville A, Patnaik MM, Lapierre V, Badaoui B, Wagner-Ballon O, Berthon C, Braun T, Willekens C, [...] Selimoglu-Buet D
J Clin Invest, 134(22):e180738, 17 Sep 2024
Cited by: 0 articles | PMID: 39545419 | PMCID: PMC11563679
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Long-term outcome after allogeneic stem cell transplantation for GATA2 deficiency: An analysis of 67 adults and children from France and Belgium.
Sicre de Fontbrune F, Chevillon F, Fahd M, Desseaux K, Poiré X, Forcade E, Sterin A, Neven B, Gandemer V, Thepot S, Garnier A, Lioure B, Marcais A, Nguyen-Quoc S, Tavitian S, Vincent L, Donadieu J, Resche Riggon M, Chevret S, [...] Peffault de Latour R
Br J Haematol, 19 Aug 2024
Cited by: 0 articles | PMID: 39159950
Add to export list
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial.
Díez-Campelo M, López-Cadenas F, Xicoy B, Lumbreras E, González T, Del Rey González M, Sánchez-García J, Coll Jordà R, Slama B, Hernández-Rivas JÁ, Thepot S, Bernal T, Guerci-Bresler A, Bargay J, Amigo ML, Preudhomme C, Fenwarth L, Platzbecker U, Götze KS, [...] Fenaux P
Lancet Haematol, 11(9):e659-e670, 18 Jul 2024
Cited by: 0 articles | PMID: 39033767
Add to export list
Eltrombopag in Chronic Myelomonocytic Leukemia With Severe Thrombocytopenia. A Gfm Study
Itzykson R, Rabian F, Chevret S, Gruson B, Thepot S, Walter-Petrich A, Braun T, Vey N, Diaz JMT, Peterlin P, TOMA A, D'Aveni M, Delaunay J, Legros L, Droin N, Chermat F, Adès L, Sapena R, Solary E, [...] Lusina D
Research Square, 21 Mar 2024
Cited by: 0 articles | PPR: PPR825920
Add to export list Preprint v1
CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia
Deschamps P, Wacheux M, Gosseye A, Morabito M, Pagès A, Lyne A, Alfaro A, Rameau P, Imanci A, Chelbie R, Marchand V, Renneville A, Patnaik M, Lapierre V, Badaoui B, Wagner-Ballon O, Berthon C, Braun T, Willekens C, [...] Selimoglu-Buet D
bioRxiv, 13 Mar 2024
Cited by: 0 articles | PPR: PPR819445
Add to export list Preprint
Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens.
Sébert M, Freiman L, Chaffaut C, Guerci A, Peterlin P, Thépot S, Beyne-Rauzy O, Park S, Cluzeau T, Chermat F, Fenaux P, Preudhomme C, Clappier E, Chevret S, Adès L, Duployez N, Duchmann M
Leukemia, 38(4):918-922, 17 Feb 2024
Cited by: 0 articles | PMID: 38368440
Add to export list
Targeting Heterochromatin Eliminates Chronic Myelomonocytic Leukemia Malignant Stem Cells Through Reactivation of Retroelements and Innate Immune pathways
Hidaoui D, Porquet A, Chelbi R, Bohm M, Polyzou A, Alcazer V, Depil S, Imanci A, Morabito M, Renneville A, Sélimoglu-Buet D, Thépot S, Itzykson R, Laplane L, Droin N, Trompouki E, Elvira-Matelot E, Solary E, Porteu F
bioRxiv, 02 Feb 2024
Cited by: 0 articles | PPR: PPR800686
Add to export list Preprint
Hypomethylating agent monotherapy in core binding factor acute myeloid leukemia: a French multicentric retrospective study.
Gabellier L, Peterlin P, Thepot S, Hicheri Y, Paul F, Gallego-Hernanz MP, Bertoli S, Turlure P, Pigneux A, Guieze R, Ochmann M, Malfuson JV, Cluzeau T, Thomas X, Tavernier E, Jourdan E, Bonnet S, Tudesq JJ, Raffoux E
Ann Hematol, 103(3):759-769, 26 Jan 2024
Cited by: 0 articles | PMID: 38273140 | PMCID: PMC10867066
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
[Myelodysplastic syndrome : prognostic factors].
Gyan E, Thépot S
Bull Cancer, 110(11):1141-1146, 01 Aug 2023
Cited by: 0 articles | PMID: 37537115
Add to export list Review
Adenovirus F41 infection and liver cytolysis in adult hematopoietic stem cell transplant recipients.
Lefeuvre C, Thepot S, Mercier-Delarue S, Bouille T, Michonneau D, Le Goff J, Salmona M
J Med Virol, 95(7):e28922, 01 Jul 2023
Cited by: 0 articles | PMID: 37386906
Add to export list
CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study.
Peterlin P, Le Bris Y, Turlure P, Chevallier P, Ménard A, Gourin MP, Dumas PY, Thepot S, Berceanu A, Park S, Hospital MA, Cluzeau T, Bouzy S, Torregrosa-Diaz JM, Drevon L, Sapena R, Chermat F, Ades L, Dimicoli-Salazar S, [...] Fenaux P
Lancet Haematol, 10(7):e521-e529, 25 May 2023
Cited by: 0 articles | PMID: 37245522
Add to export list
Relationship between comorbidities, mutational profile, and outcome after intensive chemotherapy in patients older than 60 years with acute myeloid leukemia: Assessment of different risk scores.
Bachelot A, Bouvier A, Riou J, Thepot S, Giltat A, Nunes Gomes C, Paillassa J, Jouanneau-Courville R, Renard M, Beucher A, Cottin L, Wiber M, Ribourtout B, Geneviève F, Luque Paz D, Tanguy-Schmidt A, Ugo V, Hunault-Berger M, Blanchet O, Orvain C
Am J Hematol, 98(6):922-931, 05 Apr 2023
Cited by: 0 articles | PMID: 36964937
Add to export list
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Marmouset V, Decroocq J, Garciaz S, Etienne G, Belhabri A, Bertoli S, Gastaud L, Simand C, Chantepie S, Uzunov M, Genthon A, Berthon C, Chiche E, Dumas PY, Vargaftig J, Salmeron G, Lemasle E, Tavernier E, Delage J, [...] and GFM
Clin Cancer Res, 28(23):5211-5220, 01 Dec 2022
Cited by: 4 articles | PMID: 36201165
Add to export list
Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.
Itzykson R, Santini V, Thepot S, Ades L, Chaffaut C, Giagounidis A, Morabito M, Droin N, Lübbert M, Sapena R, Nimubona S, Goasguen J, Wattel E, Zini G, Torregrosa Diaz JM, Germing U, Pelizzari AM, Park S, Jaekel N, [...] Fenaux P
J Clin Oncol, 41(10):1888-1897, 01 Dec 2022
Cited by: 6 articles | PMID: 36455187
Add to export list
A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML.
Mekinian A, Zhao LP, Chevret S, Desseaux K, Pascal L, Comont T, Maria A, Peterlin P, Terriou L, D'Aveni Piney M, Gourin MP, Vey N, Rauzy OB, Grobost V, Bezanahary H, Dimicoli-Salazar S, Banos A, Wickenhauser S, De Renzis B, [...] Fenaux P
Leukemia, 36(11):2739-2742, 14 Sep 2022
Cited by: 24 articles | PMID: 36104395
Add to export list
Red blood cell transfusion burden in myelodysplastic syndromes (MDS) with ring Sideroblasts (RS): A retrospective multicenter study by the Groupe Francophone des Myélodysplasies (GFM).
Jouzier C, Cherait A, Cony-Makhoul P, Hamel JF, Veloso M, Thepot S, Cluzeau T, Stamatoullas A, Garnier A, Guerci-Bresler A, Dimicoli-Salazar S, Pica GM, Cheze S, Santana C, Chermat F, Fenaux P, Park S
Transfusion, 62(5):961-973, 22 Apr 2022
Cited by: 2 articles | PMID: 35452143
Add to export list
Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic/myeloproliferative neoplasms: a French multicentre retrospective case-control study.
Péan de Ponfilly-Sotier M, Jachiet V, Benhamou Y, Lahuna C, De Renzis B, Kottler D, Voillat L, Dimicoli-Salazar S, Banos A, Chauveheid MP, Alexandra JF, Grignano E, Liferman F, Laborde M, Broner J, Michel M, Lambotte O, Laribi K, Venon MD, [...] MINHEMON (French Network of Dysimmune Disorders Associated wit Hemopathies) and GFM
Clin Exp Rheumatol, 40(7):1336-1342, 16 May 2022
Cited by: 2 articles | PMID: 35579092
Add to export list
Progressive multifocal leukoencephalopathy after durvalumab treatment for acute myeloid leukemia: A consequence of an immune reconstitution inflammatory syndrome?
Vinatier E, Poli C, Giltat A, Nunes-Gomes C, Orvain C, Hunault-Berger M, Jeannin P, Thépot S
EJHaem, 3(3):958-961, 29 May 2022
Cited by: 2 articles | PMID: 36051020 | PMCID: PMC9422031
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations.
Adès L, Duployez N, Guerci-Bresler A, Laribi K, Peterlin P, Vey N, Thepot S, Wickenhauser S, Zerazhi H, Stamatoullas A, Wattel E, Recher C, Toma A, Dimicoli-Salazar S, Braun T, Beyne-Rauzy O, Marolleau JP, Cheze S, Park S, [...] Fenaux P
Br J Haematol, 198(3):535-544, 19 Apr 2022
Cited by: 10 articles | PMID: 35438802
Add to export list
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study.
Devillier R, Forcade E, Garnier A, Guenounou S, Thepot S, Guillerm G, Ceballos P, Hicheri Y, Dumas PY, Peterlin P, Hunault-Berger M, Béné MC, Bouvier A, Chevallier P, Blaise D, Vey N, Pigneux A, Récher C, Huynh A
Blood Adv, 6(6):1804-1812, 01 Mar 2022
Cited by: 10 articles | PMID: 34525180 | PMCID: PMC8941467
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Azacitidine Omega-3 Self-Assemblies: Synthesis, Characterization, and Potent Applications for Myelodysplastic Syndromes.
Baroud M, Lepeltier E, El-Makhour Y, Lautram N, Bejaud J, Thepot S, Duval O
Pharmaceuticals (Basel), 14(12):1317, 17 Dec 2021
Cited by: 1 article | PMID: 34959720 | PMCID: PMC8706301
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post-transplant cyclophosphamide.
Jullien M, Orvain C, Berceanu A, Couturier MA, Guillaume T, Peterlin P, Garnier A, Le Bourgeois A, Klemencie M, Schmidt A, Hunault M, Daguindau E, Roussel X, Delepine P, Guillerm G, Giltat A, François S, Thepot S, Le Gouill S, [...] Chevallier P
Cancer Med, 10(20):7194-7202, 21 Sep 2021
Cited by: 2 articles | PMID: 34547182 | PMCID: PMC8525117
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold.
Lacombe V, Prevost M, Bouvier A, Thépot S, Chabrun F, Kosmider O, Lacout C, Beucher A, Lavigne C, Geneviève F, Urbanski G
Br J Haematol, 195(2):286-289, 02 Aug 2021
Cited by: 21 articles | PMID: 34340250
Add to export list
Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis.
Jullien M, Orvain C, Berceanu A, Couturier MA, Guillaume T, Peterlin P, Garnier A, Bourgeois AL, Klemencie M, Schmidt A, Hunault M, Daguindau E, Roussel X, Delepine P, Guillerm G, Giltat A, François S, Thepot S, Gouill SL, [...] Chevallier P
Transplant Cell Ther, 27(10):861.e1-861.e7, 07 Jul 2021
Cited by: 0 articles | PMID: 34245928
Add to export list

1-25 of 82 results

1 2 3 Next ...

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Partnerships & funding